Martin Henry Burrill

Apax Partners LLP engages in providing investment services. It focuses on investing in firms across the global sectors such as technology and telecommunications, services, healthcare, and consumer. The company was founded by Ronald Mourad Cohen and Alan J. Patricof in 1969 and is headquartered in London, the United Kingdom.

Jellagen Pty Ltd. produces research grade functional non-mammalian collagen products. The company was founded by Andrew Mearns Spragg and Alex Muhlholzl in May 2013 and is headquartered in Pembroke Dock, the United Kingdom.

Part of Ipca Laboratories Ltd., Onyx Research Chemicals Ltd. is a British company that operates as a parent company. The company is based in Sunderland, UK.

Source Bioscience Healthcare manufactures and supplies analytical testing laboratory products and provides laboratory services. The private company is based in Nottingham, UK.

DxS Ltd. is a personalized medicine company which engages in the development and manufacture of companion diagnostic products. Its products make use of molecular diagnostics to aid doctors and drug companies in selecting therapies for patients. It offers its products, technology, and services to the healthcare industry to enable the delivery of safe and effective medicines. The company was founded by David Whitcombe in 2001 is headquartered in Manchester, the United Kingdom.

Part of Optibiotix Health Plc, Optibiotix Ltd. is a British company that develops biological products for digestive health. The company is based in Heslington, UK. The company was founded in 2012 by Stephen Patrick O'Hara, who has been the CEO since 2012. Optibiotix was acquired by Optibiotix Health Plc on August 05, 2014 for $122.72 million.

The UK Innovation & Science Seed Fund LP, an evergreen fund, invests in seed-stage companies located in the United Kingdom. It targets companies operating in biotechnology, synthetic biology, engineering, agriculture, computer science, and environmental technology sectors. It provides equity financing for seed to early-stage transactions.

Cytox Ltd. develops products and services for neurodegenerative disorders. It develops cellular and genetic assays for Alzheimer’s disease diagnosis. The firm offers biomarker services to pharmaceutical companies conducting clinical trials with drugs for the treatment of AD and mild cognitive impairment; and drug-screening services. The company was founded by Zsuzsanna Nagy, Margaret Esiri, Roy Bicknell and James S. Chadwick in 2004 and is headquartered in Oxford, the United Kingdom.

Collagen Solutions (UK) Ltd. manufactures medical grade biomedical collagen components for use in regenerative medicines, medical devices, and in-vitro diagnostics. It offers reagents and protocols; and specific collagen formulations for applications, such as sponges, films, and powders. The company is headquartered in London, the United Kingdom.

Diagnostic Capital provides investment advice.

Part of Novacyt SAS, Yourgene Health UK Ltd. is a company that engages in developing prenatal diagnostic products for molecular testing laboratories. Yourgene Health UK Ltd. is based in Manchester, UK. Yourgene Health was acquired by ViaLogy Plc on July 04, 2014 for $64.97 million. The British company was founded in 2013.

Epipole Ltd. manufactures retinal video devices. It offers Automated image analysis, processing, Algorithm development, analytics, medical device design and machine vision. The company was founded by Craig Robertson in 2011 and is headquartered in Inverkeithing, the United Kingdom.

MIP Diagnostic Ltd. develops molecularly imprinted polymers for research purposes, diagnostics and drugs. The company was founded by Sergey Piletsky in 2015 and is headquartered in Leicester, the United Kingdom.

The Institute of Chartered Accountants of Scotland operates as a professional membership organization. The non-profit company is based in Edinburgh, UK. The British company was founded by Janice Margaret Brown and Sundeep Bahanda. The CEO is Bruce Cartwright.

Novel Technologies Holdings Ltd. operates as an investment holding company. The company was founded on May 24, 2017 and is headquartered in Manchester, the United Kingdom.

Quotient Diagnostics Ltd. develops diabetes testing technology. It offers pharmaceuticals, in vitro diagnostics and medical devices. The company was founded in December 2002 and is headquartered in Walton-on-Thames, the United Kingdom.

Onyx Scientific Ltd. provides pharmaceutical chemistry services. It offers lead optimization, chemical synthesis and process development, solid state chemistry, generic formulations, and pharmaceutical testing services. The company was founded by Denise Bowser and Anthony Flinn in 2000 and is headquartered in Sunderland, the United Kingdom.

Platform Diagnostics Ltd. develops vitro diagnostics products. It develops POC diagnostic devices based on capillary agglutination technology, a reagent that combines with an analyte in blood and urine samples, and forms an agglutinate of molecules. The company was founded by Damian Bond in 2002 and is headquartered in Ossett, the United Kingdom.

BgenuineTec Inc. engages in the development and sale of biometric technology products. The company provides biometric certification and authentication services, physical access systems, fingerprint image sensors, and related software. The company was founded in November 2005 and is headquartered in Tokyo, Japan.